profit margin was slightly brought down by 0.9% of gross profit margin due to turnaround costs and the rise of main raw material prices from tight supply plus greater crude oil prices. 2. In Q2 2018
MTHB, increased by 885 MTHB comparing to 2016 or 29.1% due to higher sales volumes plus Ethylene and Glycerin price increase. The rise of Ethylene price was caused by turnaround of North East Asia
declined yoy whereas revenue per head remained on the rise. The increase of revenue per head was Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9 mth 9 mth % Unit : THB million 2019 2018 change
procuring program rights and entered into a negotiation with the Company over the return of an outstanding amount of program rights and changed the entity who will be responsible for purchasing program rights
for the period 93 90 66 Other comprehensive income 0.5 0 0 Total comprehensive income for the period 93 90 66 FINANCIAL RATIOS Return on Assets (%) 6.76 6.88 6.77 Return on Equity (%) 21.69 20.44 20.17
for the period 86 115 35 Other comprehensive income 0.4 0 0 Total comprehensive income for the period 86 115 35 FINANCIAL RATIOS Return on Assets (%) 6.84 9.36 10.57 Return on Equity (%) 19.17 24.72
Profit for the period 86 115 91 Other comprehensive income 0.4 0 0 Total comprehensive income for the period 86 115 91 FINANCIAL RATIOS Return on Assets (%) 6.84 9.36 9.73 Return on Equity (%) 19.17 24.72
%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
revenue: average prices have resumed an upward trend having fluctuated somewhat over the quarter due to product mix impact. This upward trend is set to continue as input prices such as fuel rise. Saraburi
period 93 90 86 Other comprehensive income 0.5 0 0.4 Total comprehensive income for the year 93 90 86 FINANCIAL RATIOS Return on Assets (%) 6.76 6.88 6.84 Return on Equity (%) 21.69 20.44 19.17 Net Profit